| 45.06 0.28 (0.63%) | 07-24 15:59 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 52.9  |
1-year : | 53.59 |
| Resists | First : | 45.29 |
Second : | 45.88 |
| Pivot price | 45.12 |
|||
| Supports | First : | 44.34 | Second : | 36.89 |
| MAs | MA(5) : | 45.02 |
MA(20) : | 45.09 |
| MA(100) : | 44.96 |
MA(250) : | 42.63 |
|
| MACD | MACD : | -0.2 |
Signal : | -0.2 |
| %K %D | K(14,3) : | 35.7 |
D(3) : | 39.6 |
| RSI | RSI(14): 48.1 |
|||
| 52-week | High : | 47.06 | Low : | 37.17 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ PDN ] has closed above bottom band by 42.3%. Bollinger Bands are 62.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 11 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 45.26 - 45.49 | 45.49 - 45.71 |
| Low: | 44.48 - 44.71 | 44.71 - 44.95 |
| Close: | 44.68 - 45.04 | 45.04 - 45.42 |
The Fund seeks to track the results of RAFI Fundamental Select Developed ex US 1500 Index. The Fund invests in securities that comprise the Underlying Index which is comprised of approximately 1,500 common stocks and is designed to track the performance of small and mid-sized developed market excluding US companies.
Thu, 16 Jul 2026
Discipline and Rules-Based Execution in PDN Response - Stock Traders Daily
Mon, 13 Jul 2026
FNDC: Small- And Mid-Cap International ETF With An Edge (NASDAQ:SCZ) - Seeking Alpha
Sun, 14 Jun 2026
3 ETFs Giving Ready-Made Access to the Discounted International Small-Cap Space - MarketBeat
Tue, 24 Mar 2026
PXH: Emerging Markets ETF With Solid Value, Overweight In China (NYSEARCA:PXH) - Seeking Alpha
Mon, 22 Sep 2025
ETFs Investing in AbCellera Biologics, Inc. Stocks - TradingView
Fri, 19 Apr 2024
Trading (PDN) With Integrated Risk Controls - Stock Traders Daily
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
AMEX
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Asset Management
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|